There is a potential explanation for the beneficial effect of isoflavones, mostly in women with ER/PR-negative BC: isoflavones are more likely to bind to the ER and act as estrogen agonists when circulating estrogen levels are low [60]. The gene discussed is ESR1; the disease is breast cancer.